Legha SS - Search Results

1

Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.

Legha SS, Blumenschein GR, Buzdar AU, Hortobagyi GN, Bodey GP. Legha SS, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1961-4. Cancer Treat Rep. 1979. PMID: 526929

2

High-dose AMSA and bone marrow rescue in patients with solid tumors.

Zander AR, Spitzer G, Legha S, Dicke DA, Verma DS, Johnston DA, Vellekoop L, Beran M, Schell F, Minnhaar G, Blumenschein GR, Bodey GP. Zander AR, et al. Cancer Treat Rep. 1982 Feb;66(2):385-6. Cancer Treat Rep. 1982. PMID: 7034935

3

Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.

Legha SS, Latreille J, McCredie KB, Bodey GP. Legha SS, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2001-3. Cancer Treat Rep. 1979. PMID: 526933 No abstract available.

4

Adriamycin and mitomycin C: possible synergistic cardiotoxicity.

Buzdar AU, Legha SS, Tashima CK, Hortobagyi GN, Yap HY, Krutchik AN, Luna MA, Blumenschein GR. Buzdar AU, et al. Among authors: legha ss. Cancer Treat Rep. 1978 Jul;62(7):1005-8. Cancer Treat Rep. 1978. PMID: 688243

5

Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.

Legha SS, Ajani JA, Blumenschein GR, Hortobagyi GN, Buzdar AU. Legha SS, et al. Cancer. 1984 May 1;53(9):1836-40. doi: 10.1002/1097-0142(19840501)53:9<1836::aid-cncr2820530906>3.0.co;2-p. Cancer. 1984. PMID: 6231092

6

Phase II evaluation of AMSA in adult sarcomas.

Yap BS, Plager C, Benjamin RS, Murphy WK, Legha SS, Bodey GP. Yap BS, et al. Among authors: legha ss. Cancer Treat Rep. 1981 Mar-Apr;65(3-4):341-3. Cancer Treat Rep. 1981. PMID: 6263473

7

Phase II study of spirogermanium in the treatment of metastatic breast cancer.

Pinnamaneni K, Yap HY, Legha SS, Blumenschein GR, Bodey GP. Pinnamaneni K, et al. Among authors: legha ss. Cancer Treat Rep. 1984 Sep;68(9):1197-8. Cancer Treat Rep. 1984. PMID: 6478457 No abstract available.

8

Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer.

Hortobagyi GN, Yap HY, Blumenschein GR, Buzdar AU, Barnes BC, Legha SS, Wiseman CL. Hortobagyi GN, et al. Among authors: legha ss. Cancer. 1983 Mar 1;51(5):769-72. doi: 10.1002/1097-0142(19830301)51:5<769::aid-cncr2820510503>3.0.co;2-s. Cancer. 1983. PMID: 6600415

9

Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine.

Hortobagyi GN, Yap HY, Wiseman CL, Blumenschein GR, Buzdar AU, Legha SS, Gutterman JU, Hersh EM, Bodey GP. Hortobagyi GN, et al. Among authors: legha ss. Cancer Treat Rep. 1980 Jan;64(1):157-9. Cancer Treat Rep. 1980. PMID: 6991103 Clinical Trial.

10

Prognostic value of prechemotherapy skin tests in patients with metastatic breast carcinoma.

Hortobagyi GN, Smith TL, Swenerton KD, Legha SS, Buzdar AU, Blumenschein GR, Gutterman JU, Hersh EM. Hortobagyi GN, et al. Among authors: legha ss. Cancer. 1981 Mar 15;47(6):1369-76. doi: 10.1002/1097-0142(19810315)47:6<1369::aid-cncr2820470622>3.0.co;2-3. Cancer. 1981. PMID: 7226061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters